News

While "sell in May, go away" has historical roots and some statistical support, many Wall Street strategists argue seasonal ...
Sometimes, a night at the ballpark becomes something entirely distinctive—a bizarre spectacle where the story has less to do ...
In February, AstraZeneca and Daiichi Sankyo teased the results of their pivotal trial of Enhertu in HER2-low breast cancer, and, at ASCO, they finally revealed the data – with the numbers every ...
An ideology s durability and strength is often misunderstood by many Its fiercest believers will always find little to complain but neutral observers can also be sometimes lulled into what is called t ...